Bioventix PLC
LSE:BVXP
Bioventix PLC
LSE:BVXP
Price:
4 375 GBX
Market Closed
Updated:
May 17, 2024
Bioventix PLC
EPS (Diluted)
|
Bioventix PLC
EPS (Diluted) Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bioventix PLC
LSE:BVXP
|
EPS (Diluted)
£1
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-136%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
EPS (Diluted)
-$1
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
EPS (Diluted)
-$3
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
EPS (Diluted)
-£1
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
EPS (Diluted)
£0
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
See Also
What is Bioventix PLC's EPS (Diluted)?
EPS (Diluted)
1.6
GBP
1.6
GBP
Based on the financial report for Dec 31, 2023, Bioventix PLC's EPS (Diluted) amounts to 1.6 GBP.
What is Bioventix PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
17%
17%
Over the last year, the EPS (Diluted) growth was 2%. The average annual EPS (Diluted) growth rates for Bioventix PLC have been 8% over the past three years , 9% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
